ArticleFrontiers in neurology2025
Assessing misophonia as a potential comorbidity in migraine patients compared to controls: a cross-sectional study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the prevalence and symptom severity of misophonia among individuals with migraine, and to explore its clinical and psychological correlates. Background: Misophonia is a neurobehavioral condition characterized by intense emotional and physiological reactions to specific everyday sounds, such as chewing or tapping. Although misophonia has been associated with increased sensory sensitivity and psychiatric comorbidities, its relationship with other sensory processing disorders-particularly migraine-remains underexplored. Methods: In this cross-sectional study, 205 migraine patients and 205 healthy controls completed validated scales assessing misophonia symptoms, psychiatric comorbidities, and migraine-related disability. Statistical comparisons and univariate linear regression analyses were performed to identify predictors of misophonia. Results: Our findings revealed a significantly higher prevalence of misophonia among individuals with migraine compared to healthy controls (44.9% vs. 17.6%). Misophonia symptoms were not only more common but also more severe in the migraine group. Migraine patients with comorbid misophonia scored significantly higher on the Headache Impact Test-6 and all components of the Migraine Disability Assessment Scale compared to those without misophonia. Sensory sensitivities such as photophobia, phonophobia, osmophobia, and allodynia were also more frequent and intense among migraine patients with misophonia. Furthermore, these patients exhibited significantly higher levels of anxiety, stress, and obsessive-compulsive symptoms. Regression analyses revealed that stress, obsessive-compulsive symptoms, allodynia, and migraine-related disability were significant predictors of misophonia scores. Conclusion: Misophonia is a common and clinically significant comorbidity in migraine, associated with heightened sensory sensitivities, increased psychiatric burden, and greater functional impairment. The co-occurrence of these conditions may be underpinned by shared neurobiological mechanisms, particularly networks mediating sensory-emotional integration. Further longitudinal and neurobiological research is warranted to clarify causal relationships and inform targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.